Ignite Creation Date:
2025-12-24 @ 7:24 PM
Ignite Modification Date:
2026-02-21 @ 9:24 PM
Study NCT ID:
NCT04644003
Status:
COMPLETED
Last Update Posted:
2024-11-08
First Post:
2020-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)
Sponsor:
Stalicla SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
STP1-C004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None